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Physical activity can prevent functional decline associ-ated with age and promote global health status. Recent 
reports suggested that physical activity can prevent cognitive 
decline and progression for dementia, including Alzheimer 
disease,1–6 and the explanation for this relation still remains 
a matter of debate.7 Several reasons can explain the protec-
tive effect of physical activity on the evolution for cognitive 
impairment. Beneficial effects of physical exercise can be 
observed in mental and social stimulation and can be inte-
grated in a healthier life status to explain the association.8 
More biological explanations have been proposed: physical 
activity can improve cerebral blood flow, reduce vascular risk 
factors, decrease secretion of stress hormones, and stimulate 
plasticity.9 Recently physical activity has been associated with 
enhancement of endothelial function, counteracting the loss 
of vasodilatory function associated with aging.10,11 Some data 
support a decreased progression of intima-media thickness 
associated with physical activity.12
In this study we aimed to study the impact of physical 
activity on the evolution for cognitive impairment and dementia 
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in a cohort of old people with white matter changes (WMC) 
living independently who were followed prospectively during 
3 years with comprehensive cognitive evaluation and careful 
control of concomitant factors implicated in disability.
Materials and Methods
The LADIS (Leukoaraiosis and Disability) study is a prospective mul-
tinational European project investigating the independent impact of 
WMC on the transition to disability in the elderly. The rationale, meth-
odology, and baseline assessment have been described previously.13,14 
Inclusion criteria for the study were: (1) 65 to 84 years of age; (2) 
changes in WMC on MRI of any degree, according to the scale of 
Fazekas;15 and (3) no disability, as determined by the Instrumental 
Activities of Daily Living scale.16 Patients were enrolled because of 
minor neurological, cognitive, mood, or motor complaints or inciden-
tal findings on cranial imaging caused by nonspecific events, without 
impact on daily living activities, as detailed elsewhere.12 Subjects were 
evaluated at baseline and yearly during 3 years with a comprehensive 
clinical and functional protocol that included registry of demographic 
factors, vascular risk factors including stroke and diabetes, comorbidi-
ties, depression, quality of life, and neuropsychological evaluation.12 
During the interview physical activity was assessed and defined ac-
cording to the American Heart Association Scientific Position (at least 
30 minutes of activity on at least 3 days per week).17 Patients were 
classified as physically active or inactive according to this definition.
For those patients who could not attend the clinical visit, a phone 
interview was performed.14 Investigators were provided with a specif-
ically developed handbook with guidelines for applying criteria and 
tools and trained medical personnel used a structured and compre-
hensive questionnaire together with review of the available records.13
Neuropsychological Evaluation and Cognitive 
Criteria
The LADIS neuropsychological battery has been described in detail 
elsewhere.14 References from the battery neuropsychological tests are 
given in Supplemental Appendix I. In short, the neuropsychological 
battery included the Mini-Mental State Examination as a global mea-
sure of cognitive function; the Vascular Dementia Assessment Scale 
cognitive subscale (VADAS-Cog) as a comprehensive instrument to 
assess orientation, language, ideational and constructional praxis, im-
mediate memory and delayed recall, attention and speed of mental 
processing; and the Stroop and Trail Making tests as measures of ex-
ecutive function. Additionally, in the follow-up clinical visits, patient 
cognitive status was classified into the following groups: (1) demen-
tia; (2) cognitive impairment not dementia; or (3) no cognitive impair-
ment. For this purpose, we used the following criteria and definitions 
(references are given in Supplemental Appendix I). We considered 2 
types of cognitive impairment not dementia: (1) amnestic mild cogni-
tive impairment, according to Petersen RC, Doody R, Kurz A, Mohs 
RC, Morris JC, Rabins PV, et al. Current concepts in mild cognitive 
impairment. Arch Neurol. 2001;58:1985–1992. (defined as mem-
ory complaint, preferably corroborated by an informant; impaired 
memory function for age and education, preserved general cognitive 
function, intact activities of daily living and no dementia); or (2) vas-
cular cognitive impairment without dementia (defined as evidence of 
cognitive impairment and clinical consensus to identify significantly 
related vascular features, exclusion of dementia when impairments 
were not sufficiently severe to interfere with social or occupational 
functioning or when impairments were more focal than the global 
requirement for a diagnosis of dementia). We considered the follow-
ing clinical criteria for subtypes of dementia: Alzheimer disease ac-
cording to the National Institute of Neurological and Communicative 
Disorders and Stroke–Alzheimer’s Disease and Related Disorders 
Association (NINCDS-ADRDA) Work Group, vascular demen-
tia according to National Institute of Neurological Disorders and 
Stroke (NINDS) Association Internationale pour la Recherche et 
l'Enseignement en Neurosciences (AIREN) criteria, subtype of 
subcortical vascular dementia according to Erkinjuntti T, Inzitari 
D, Pantoni L, Wallin A, Scheltens P, Rockwood K, et al. Research 
criteria for subcortical vascular dementia in clinical trials. J Neural 
Transm Suppl. 2000;59:23–30. and frontotemporal dementia accord-
ing to McKhann GM, Albert MS, Grossman M, Miller B, Dickson 
D, Trojanowski JQ; Work Group on Frontotemporal Dementia and 
Pick's Disease. Clinical and pathological diagnosis of frontotemporal 
dementia: report of the Work Group on Frontotemporal Dementia and 
Pick's Disease. Arch Neurol. 2001;58:1803–1809. The criteria for 
Alzheimer disease with vascular component were considered when 
the investigator judgment considered that the clinical picture was due 
simultaneously to Alzheimer disease and vascular dementia.
Progression for cognitive impairment (or cognitive decline) during 
the study was defined clinically as a change in the clinical cognitive 
diagnosis in the different times of follow-up. That is, decline was de-
termined by: (1) transition from no cognitive impairment to cognitive 
impairment no dementia; or (2) transition from cognitive impairment 
no dementia to dementia; or (3) transition from no cognitive impair-
ment to dementia.
MRI Study
MRI was performed at entry and at the end of the study following 
a protocol previously described.13 The degree of WMC severity was 
rated on fluid-attenuated inversion recovery sequences by central 
readers blind to the clinical data using the 3 classes (mild, moderate, 
and severe) in the revised version of the visual scale of Fazekas and 
colleagues.15 Medial temporal lobe atrophy was assessed on coronal 
T1-weighted sequences using the medial temporal atrophy scale.18
Statistical Analysis
The influence of physical activity (recorded at baseline) on the cogni-
tive status during follow-up was assessed using Cox proportional hazard 
models that relied on a noninformative censoring process. We consid-
ered as a dependent variable the last cognitive evaluation as described 
in the Methods section, and progression for cognitive impairment was 
considered as described in Methods section, with a change between 
baseline and last follow-up. We performed different models considering 
the cognitive diagnosis at the end of follow-up: any cognitive impair-
ment (dementia and cognitive impairment not dementia); or diagnosis 
of dementia, Alzheimer disease, and vascular dementia. We considered 
the following independent variables: age, education, medial temporal 
atrophy, and WMC severity. Age and educational level were consid-
ered continuous variables. Medial temporal atrophy and WMC severity 
were considered categorical variables. We controlled analysis for the 
variables found relevant in predicting cognitive impairment in previous 
publications (diabetes and previous stroke)19 and for global cognitive 
status at baseline using Mini-Mental State Examination because it was 
found in our sample to be sensitive to the evolution for cognitive impair-
ment and dementia.20 Data were analyzed using SPSS 16.0 software.
Results
Six hundred thirty-eight subjects were included (74.1 years, SD 
5; 55% women; 9.6 years of educational level, SD 3.8). Baseline 
characteristics, including vascular risk factors of the study popula-
tion, were already described;19 in short, concerning relevant risk 
factors for the present study, 29.6% of the study population had pre-
vious stroke and 14.6% were diabetic at baseline (Table 1). WMC 
severity at baseline was as follows: mild, 44%; moderate, 31%; 
and severe, 25%. At entry, 63.8% of subjects performed physi-
cal activity. At the end of follow-up, vital status or Instrumental 
Activities of Daily Living scale was possible to ascertain in 633 
patients (99.1% of initial sample). Fifty-one patients missed com-
plete cognitive evaluation in any follow-up clinical visit; for those 
51 patients, no cognitive diagnosis was attributed.
Considering the cognitive diagnosis ascertained in the 
last clinical visit, dementia was diagnosed in 90 patients 
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(vascular dementia, 54; Alzheimer disease with vascu-
lar component, 34; frontotemporal dementia, 2), and 147 
patients had cognitive impairment not dementia (vascular 
cognitive impairment without dementia, 86; mild cognitive 
impairment, 61).
Using Cox regression analysis we found that physical activ-
ity measured at baseline was an independent protective factor 
for cognitive impairment overtime (dementia and cognitive 
impairment not dementia; Table 2). The preventive effect of 
physical activity for the progression for cognitive impair-
ment was unchanged when controlling for diabetes (β=−0.35, 
P=0.021; hazard ratio, 0.71; 95% CI, 0.524–0.949).
•	 Considering dementia irrespective of pathogenesis, phys-
ical activity reduced the risk of dementia (Table 3)
•	 Considering patients with criteria for Alzheimer disease 
(N=34), physical activity did not influence evolution for 
dementia (Table 4).
•	 Considering patients with criteria for vascular dementia 
(N=54) we found that physical activity reduced in more 
than half the risk for vascular dementia (Table 5), even 
controlling for incident stroke (β=−0.80, P=0.015; haz-
ard ratio, 0.45; 95% CI, 0.236–0.858).
Because the impact of physical activity over time could be 
due to cognitive differences already at baseline, we repeated 
the analysis considering Mini-Mental State Examination at 
baseline. Even so, physical activity at baseline remained an 
independent predictor of vascular dementia, reducing in half 
the risk for future vascular dementia (β=−0.71, P=0.032; haz-
ard ratio, 0.49; 95% CI, 0.257–0.940; Supplemental Table VI 
in Appendix II). Considering other outcomes, we controlled 
Table 1. Baseline Patient Characteristics (N=639)
Total
With Physical  
Activity (64%)
No Physical  
Activity (36%)
P  
Value
Age, y, mean±SD 74.1±5 73.9±5 74.5±5 0.2
Female/male 55%/45% 53%/46% 57%/43% 0.4
Educational level,  
y of schooling
9.6±3.8 10.1±3.6 8.7±3.9 0.000
WMC severity 0.005
 Mild 283 (44%) 191/407 93/231
 Moderate 197 (31%) 133/407 64/231
 Severe 158 (25%) 83/407 74/231
MTA score 1.1±0.8 1.1±0.8 1.2±0.9 0.04
MMSE score, 
mean±SD
27.36±2.4 27.6±2.2 26.9±2.7 0.000
WMC indicates white matter changes; MTA, medial temporal atrophy; 
MMSE, Mini-Mental State Examination.
Table 2. Cox Proportional Hazards Model
β HR P Value 95% CI
Age 0.026 1.026 0.070 0.998 1.055
Educational level –0.050 0.951 0.007 0.917 0.986
Sex 0.184 1.202 0.186 0.915 1.580
WMC severity 0.038
  WMC severity  
(moderate vs mild)
0.353 1.423 0.039 1.017 1.991
  WMC severity  
(severe vs mild)
0.411 1.508 0.020 1.066 2.134
MTA 0.023
 MTA (1 vs 0) 0.080 1.083 0.689 0.733 1.600
 MTA (2 vs 0) 0.416 1.516 0.057 0.987 2.328
 MTA (3 vs 0) 0.642 1.901 0.019 1.109 3.256
 MTA (4 vs 0) 1.135 3.112 0.040 1.055 9.185
Physical activity –0.447 0.640 0.002 0.482 0.849
Dependent variable: cognitive decline (dementia and cognitive decline not 
dementia in last clinical evaluation (237 subjects).
CI indicates confidence interval; HR, hazard ratio; MTA, medial temporal 
atrophy; WMC, white matter changes.
Table 3. Cox Proportional Hazards Model
β HR P Value 95% CI
Age 0.033 1.034 0.163 0.987 1.084
Educational level –0.016 0.985 0.600 0.929 1.044
Sex –0.106 0.899 0.650 0.569 1.421
WMC severity 0.033
  WMC severity  
(moderate vs mild)
0.110 1.117 0.731 0.596 2.093
  WMC severity  
(severe vs mild)
0.681 1.976 0.017 1.127 3.463
MTA 0.000
 MTA (1 vs 0) 0.397 1.488 0.362 0.633 3.496
 MTA (2 vs 0) 1.363 3.907 0.002 1.666 9.160
 MTA (3 vs 0) 1.738 5.686 0.000 2.205 14.663
 MTA (4 vs 0) 2.520 12.430 0.000 3.263 47.348
Physical activity –0.492 0.611 0.043 0.380 0.984
Dependent variable: dementia in last clinical evaluation (90 subjects).
CI indicates confidence interval; HR, hazard ratio; MTA, medial temporal 
atrophy; WMC, white matter changes.
Table 4. Cox Proportional Hazards Model
β HR P Value 95% CI
Age 0.060 1.062 0.142 0.980 1.151
Educational level –0.049 0.952 0.347 0.860 1.055
Sex –0.823 0.439 0.043 0.197 0.976
WMC severity 0.179
  WMC severity  
(moderate vs mild)
–0.661 0.517 0.228 0.176 1.512
  WMC severity  
(severe vs mild)
0.358 1.431 0.415 0.605 3.383
MTA 0.010
 MTA (1 vs 0) –0.976 0.377 0.113 0.113 1.259
 MTA (2 vs 0) 0.785 2.192 0.144 0.765 6.283
 MTA (3 vs 0) 0.880 2.411 0.186 0.655 8.873
 MTA (4 vs 0) 1.381 3.979 0.134 0.655 24.187
Physical activity 0.089 1.093 0.823 0.504 2.369
Dependent variable: Alzheimer disease with vascular component in last 
clinical evaluation (34 subjects).
CI indicates confidence interval; HR, hazard ratio; MTA, medial temporal 
atrophy; WMC, white matter changes.
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also results for Mini-Mental State Examination score, and 
results remained unchanged considering cognitive impairment 
(dementia and not dementia altogether; Supplemental Table 
VII in Appendix II) and were lost for dementia, probably due 
to the different types of predictors of the dementias included 
(Supplemental Table VIII in Appendix II).
Discussion
Our results showed that among nondisabled old people with 
WMC, physical activity reduced the risk for cognitive impair-
ment and vascular dementia, independently of the severity of 
WMC even controlling for educational level, age, and temporal 
atrophy and for risk factors found to be predictive of dementia.
Previous studies suggested a beneficial impact of physi-
cal activity on the progression for cognitive impairment and 
dementia, even for subjects with Alzheimer disease and a 
reduced amount of exercise.1–6 Recently, a panel reviewed 
evidence on the prevention for Alzheimer disease; although 
globally physical activity (particularly high levels) have been 
associated with decreased risk of Alzheimer disease, associa-
tions were not always significant after adjusting for confound-
ing factors risk and in some studies the risk estimates were in 
the direction indicating increased risk of Alzheimer disease.21
A recent meta-analysis addressed the preventive effect of 
physical activity for vascular dementia, but among the 5 studies 
included, only 1 showed a significant association between 
physical activity and risk for vascular dementia. Several 
studies reported no association between physical activity 
and all dementias or vascular dementia.22 Moreover, those 
studies, with 1 exception,23 did not control for imaging data, 
namely WMC or medial temporal atrophy, and most of them 
did not control for cognitive status at inclusion.23–27 Our study 
has some limitations, mostly related with sample selection, 
which does not represent the community. Participants were 
selected due to minor complaints and probably represent the 
first moment when nondisabled elderly with cerebral WMC 
seek medical attention. Other limitations consist of length 
of the study (3 years) that was probably short to allow a 
larger number of conversions for cognitive impairment and 
dementia and interfere with the power of the study. However, 
longer follow-up would implicate more missing values and 
compromise also statistical approach. Nevertheless, our 
study has several strengths providing a unique opportunity 
to evaluate prognostic factors of cognitive impairment and 
subtypes of dementia over time when evaluating older people 
with a particular vascular profile and living independently 
and allowed a very comprehensive control for risk factors and 
comorbidities implicated in disability, including brain imaging 
variables.19 In the LADIS study, severe WMC were associated 
with worse motor performance using simple clinical measures 
of balance and gait28 and with an increase risk of falls,29 and 
at that time, it seemed conceivable that exercise could have 
a protective effect in delaying transition to disability. In the 
present study we looked for the particular effect of physical 
activity on the transition for cognitive impairment. We already 
described that severe WMC predicted evolution for cognitive 
impairment and vascular dementia. We found now that, even 
taking into consideration the effect of severe WMC, physical 
activity implicated a reduced risk for the transition to vascular 
dementia. Among the reasons that could explain the protective 
effect of physical activity on the transition for cognitive 
impairment, reduced physical activity could be a subtle 
manifestation of an incipient cognitive impairment. Although 
we cannot exclude premild cognitive impairment in our 
sample, we controlled results for a global cognitive measure 
at baseline (Mini-Mental State Examination) and found that 
physical activity remained protective, reducing in half the 
risk to develop vascular dementia. The same consistency of 
results was found when controlling for cognitive impairment 
(dementia and cognitive impairment not dementia together), 
but was lost for dementia, because this group includes 
Alzheimer disease and vascular dementia, and, as published 
previously, the cognitive predictors were quite different.19
In the LADIS sample, among all vascular risk factors stud-
ied, diabetes was the only independent predictor of cognitive 
decline (including dementia and cognitive decline not demen-
tia) independent of the effect of WMC and medial temporal 
lobe atrophy, and stroke was a prognostic factor for vascular 
dementia. For this reason we controlled our findings for both 
diseases, and the protective effect of physical activity remained 
unchanged. Our data support the conviction that older subjects 
with vascular risk factors and evidence for vascular cerebral 
damage benefit from regular physical activity. We think that 
relation between physical activity and cognitive impairment 
should be further studied by interventional studies.
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Table 5. Cox Proportional Hazards Model
β HR P Value 95% CI
Age 0.029 1.029 0.352 0.969 1.093
Educational level 0.008 1.008 0.835 0.937 1.084
Sex 0.320 1.377 0.300 0.752 2.519
WMC severity 0.041
  WMC severity  
(moderate vs mild)
0.624 1.867 0.156 0.787 4.425
  WMC severity  
(severe vs mild)
1.029 2.798 0.012 1.255 6.240
MTA 0.002
 MTA (1 vs 0) 1.960 7.102 0.058 0.936 53.890
 MTA (2 vs 0) 2.654 14.208 0.011 1.861 108.484
 MTA (3 vs 0) 3.125 22.751 0.003 2.807 184.406
 MTA (4 vs 0) 4.184 65.599 0.001 5.297 812.370
Physical activity –0.864 0.421 0.008 0.223 0.797
Dependent variable: vascular dementia in last clinical evaluation (54 
subjects).
CI indicates confidence interval; HR, hazard ratio; MTA, medial temporal 
atrophy; WMC, white matter changes.
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